Related and Nonrelated Parties [Axis] Related Party [Member] Product and Service [Axis] Restricted Gold [Member] Gold [Member] Class of Stock [Axis] Series C 9% Convertible Preferred Stock [Member] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Series C Preferred Stock [Member] Series D Preferred Stock [Member] Series E Preferred Stock [Member] Series F Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Noncontrolling Interest [Member] Investment, Name [Axis] Viral Clear [Member] BioSig AI Sciences, Inc. [Member] Business Combination [Axis] GLDY ServiceCo, LLC [Member] Geographical [Axis] UNITED STATES CANADA Consolidated Entities [Axis] Consolidated Entity, Excluding Consolidated VIE [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Performance Based Restricted Stock Unit [Member] Warrant [Member] Restricted Stock [Member] Streamex Exchange Corporation [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Share Purchase Agreement [Member] Third party Consultants [Member] Intangible Asset, Finite-Lived, Class [Axis] Trade Names [Member] Technology-Based Intangible Assets [Member] Securitization Platform [Member] Blockchain Integration [Member] Legal and Compliance Frame Work [Member] Developed Technology Rights [Member] Patents [Member] Intangible Asset, Indefinite-Lived, Class [Axis] Legal Contact [Member] Compliance Framework [Member] Long-Lived Asset, Class [Axis] Computer Equipment [Member] Furniture and Fixtures [Member] Testing and Demo Equipment [Member] Leasehold Improvements [Member] Legal Entity [Axis] Empress Royalty Corp [Member] Restricted [Member] Unrestricted [Member] Statistical Measurement [Axis] Maximum [Member] Brinks Bailee Agreement [Member] Two Related Party [Member] Streamex Ltd [Member] Title and Position [Axis] Chief Invest Officer [Member] General Counsel Officers [Member] Premium Finance Agreement [Member] Vesting [Axis] Share-Based Payment Arrangement, Tranche One [Member] Share-Based Payment Arrangement, Tranche Two [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Minimum [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 3 [Member] Measurement Frequency [Axis] Fair Value, Nonrecurring [Member] Developed Technology [Member] Measurement Input Type [Axis] Measurement Input Common Stock Price [Member] Measurement Input Indicated Conversion Price [Member] Measurement Input Floor Price [Member] Measurement Input, Prepayment Rate [Member] Measurement Input Prepayment Premium [Member] Measurement Input Registration Probability [Member] Fair Value, Inputs, Level 1 [Member] Preferred Stock [Member] Convertible Preferred Stock [Member] Investor [Member] Sale of Stock [Axis] Over-Allotment Option [Member] Sales Agreement [Member] Award Type [Axis] Plan Name [Axis] 2023 Long-Term Incentive Plan [Member] Restricted Stock Units (RSUs) [Member] Third Party Consultant [Member] Common Stock One [Member] Common Stock Two [Member] Common Stock Three [Member] Common Stock Four [Member] Common Stock Five [Member] Performance Shares [Member] Share-Based Payment Arrangement, Tranche Three [Member] Share Based Compensation Award Tranche Four [Member] Share Based Compensation Award Tranche Five [Member] Restricted Stock One [Member] Restricted Stock Two [Member] Share Based Compensation Award Tranche [Member] Viral Clear Pharmaceuticals Inc [Member] Equity Option [Member] Exercise Price Range [Axis] Options Under 9.99 [Member] Options 10.00 To 19.99 [Member] Options 20.00 To 49.99 [Member] Options 50.00 To 69.99 [Member] Measurement Input, Share Price [Member] Measurement Input, Price Volatility [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Dividend Rate [Member] Measurement Input, Expected Term [Member] Warrants At 0.3000 [Member] Warrants At 0.9547 [Member] Warrants At 1.7800 [Member] Warrants At 3.3640 [Member] Warrants At 4.0660 [Member] Warrants At 4.4550 [Member] Warrants At 44660 [Member] Warrants At 4.6626 [Member] Warrants At 4.9252 [Member] Warrants At 4.9290 [Member] Warrants At 5.1358 [Member] Warrants At 7.1810 [Member] Warrants At 7.5020 [Member] Warrants At 7.9630 [Member] Warrants At 9.0000 [Member] Warrants At 9.5960 [Member] Warrants At 10.0992 [Member] Warrants At 10.2600 [Member] Warrants At 10.4678 [Member] Warrants At 11.3000 [Member] Warrants At 13.2800 [Member] Warrants At 48.0000 [Member] Warrants At 61.6000 [Member] Award Date [Axis] One One Two Thousand Twenty Six [Member] One Eight Two Thousand Twenty Six [Member] Interim Executive Chairman [Member] Chief Executive Officier [Member] One Twenty Seven Two Thousand Twenty Six [Member] Two One Two Thousand Twenty Six [Member] Three Three Two Thousand Twenty Six [Member] Three Sixteen Two Thousand Twenty Six [Member] Chief Financial Officer [Member] Share-Based Payment Arrangement [Member] Performance shares And AUM [Member] Range One [Member] Bio Sig AI Sciences Inc [Member] Segments [Axis] Corporate Segment [Member] Board of Directors Chairman [Member] Chief Investment Officer [Member] Employment Agreement [Member] Performance Vesting Restricted Stock Units [Member] Third Party [Member] Six Month Anniversaries [Member] Twelve Month Anniversaries [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Listing, Par Value Per Share Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current assets: Cash Sales tax receivable Due from related party Marketable securities Other assets held for sale – gold Prepaid expenses and other assets Total current assets Non-current assets: Other assets held at cost – gold Property and equipment, net Intangible assets, net Goodwill Total non-current assets Total assets LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable and accrued expenses, including $907 and $66 to related parties as of March 31, 2026, and December 31, 2025, respectively. Dividends payable Convertible debentures, net Embedded derivative liability Total current liabilities Deferred tax liability Total liabilities Commitments and contingencies (Note 16) Mezzanine equity Redeemable Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; (liquidation preference of $105; cumulative dividends payable of $123 and $121 as of March 31, 2026, and December 31, 2025, respectively). Stockholders’ equity: Preferred stock, $0.001 par value, authorized 1,000,000 shares, designated 200 shares of Series A, 600 shares of Series B, 4,200 shares of Series C, 1,400 shares of Series D, 1,000 shares of Series E, 200,000 shares of Series F Preferred Stock and 1 Special Voting Preferred Stock. Common stock, $0.001 par value, authorized 500,000,000 shares, 97,721,696 and 49,805,275 issued and outstanding as of March 31, 2026, and December 31, 2025, respectively. Additional paid-in-capital Accumulated other comprehensive (loss) income Accumulated deficit Total stockholders’ equity attributable to Streamex Corp. Non-controlling interest Total stockholders’ equity Total liabilities, mezzanine equity and stockholders’ equity Statement [Table] Statement [Line Items] Accounts payable and accrued expenses, related parties Temporary equity, par value Temporary equity, stated value Temporary equity, shares authorized Temporary equity, shares issued Temporary equity, shares outstanding Liquidation preference Cumulative dividends Preferred stock, par value Preferred stock, shares authorized Preferred stock, voting rights Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Operating expenses: Research and development General and administrative Depreciation and amortization Total operating expenses Loss from operations Other income (expense): Interest expense, net Realized gain on sale of gold Realized gain on marketable securities Change in fair value of marketable securities Change in fair value of embedded derivative Realized loss on extinguishment of convertible debentures Realized loss on investment Gain on settlement and forgiveness of debt Other income (expense), net Total other income (expense), net Loss before income taxes Income taxes (benefit) Net loss Non-controlling interest Net loss attributable to Streamex Corp. Preferred stock dividend Preferred stock deemed dividend Net loss attributed to Streamex Corp. Common Shareholders Net loss per common share, basic Net loss per common share, diluted Weighted average number of common shares outstanding, diluted Weighted average number of common shares outstanding, diluted Comprehensive (Loss) Income: Change in foreign currency translation adjustments Total comprehensive loss Comprehensive (loss) income attributable to non-controlling interest Comprehensive loss attributable to Streamex Corp. Balance Balance, shares Stock based compensation Stock based compensation, shares Exercise of warrants Exercise of warrants, shares Net proceeds from issuance of common stock in underwritten public offering Net proceeds from issuance of common stock in underwritten public offering, shares Conversion of exchangeable shares into common stock Conversion of exchangeable shares into common stock, shares Conversion of convertible debentures into common stock Conversion of convertible debentures into common stock, shares Issuance of equity to noncontrolling interest holders Preferred stock dividend Other comprehensive loss Net (loss) income Sale of common stock under at-the- market offering, net of transaction costs Sale of common stock under-at-the market offering, net of transaction costs, shares Sale of common stock and warrants Sale of common stock and warrants, shares Common stock issued to settle accounts payable Common stock issued to settle accounts payable, shares Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to cash used in operating activities: Amortization of debt discount and issuance costs Gain on settlement and extinguishment of accounts payable Non-cash lease expense Realized gain on sale of gold Realized gain on marketable securities Change in fair value of marketable securities Change in fair value of embedded derivative Realized loss on extinguishment of convertible debentures Realized loss on investment Stock-based compensation expense Deferred income taxes Changes in operating assets and liabilities: Accounts receivable Lease receivables Sales tax receivable Prepaid expenses and other assets Accounts payable and accrued expenses Operating lease liabilities Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of marketable securities Proceeds from the sale of marketable securities Proceeds from the sale of non-marketable equity investments Proceeds from sale of gold Purchase of gold assets Net cash used in investing activity CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from sale of common stock under at-the-market offerings, net of issuance costs Proceeds from sale of common stock and warrants, net of issuance costs Repayment of finance obligation Net proceeds from issuance of common stock in underwritten public offering Proceeds from issuance of equity in subsidiary to non-controlling interest holders Repayment of convertible debentures Net cash (used in) provided by financing activities Effect of exchange rate change on cash Net (decrease) increase in cash Cash, beginning of the period Cash, end of the period Supplemental disclosures of cash flow information: Cash paid during the period for interest Cash paid during the period for income taxes Noncash investing and financing activities: Common stock issued in settlement of accounts payable Dividend payable on preferred stock charged to additional paid-in-capital Conversion of convertible debentures into common stock Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS LIQUIDITY Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] BUSINESS ACQUISITION Intangible Asset, Goodwill and Other [Abstract] GOODWILL AND INTANGIBLE ASSETS Property, Plant, and Equipment [Abstract] PROPERTY AND EQUIPMENT Investments, Debt and Equity Securities [Abstract] MARKETABLE SECURITIES Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] GOLD ASSETS STREAMEX LTD. (VIE) Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUED EXPENSES Debt Disclosure [Abstract] CONVERTIBLE DEBENTURES AND RELATED DERIVATIVE INSTRUMENTS Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Equity [Abstract] STOCKHOLDERS’ EQUITY OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS Noncontrolling Interest [Abstract] NON-CONTROLLING INTEREST Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Segment Reporting [Abstract] SEGMENT REPORTING Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Basis of Consolidation Use of estimates Foreign Currency Translation Marketable Securities Gold Assets Concentration of Assets Net Income (loss) Per Common Share Recently adopted accounting pronouncements Recently issued accounting pronouncements not yet adopted SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE SCHEDULE OF TANGIBLE AND IDENTIFIABLE INTANGIBLE ASSETS ACQUIRED AND LIABILITIES ASSUMED SCHEDULE OF CARRYING AMOUNT OF GOODWILL SCHEDULE OF INTANGIBLE ASSETS SCHEDULE OF FUTURE AMORTIZATION EXPENSE OF INTANGIBLE ASSETS SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF VAIABLE INTEREST ENTITY ASSETS AND LIABILITIES SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSE SCHEDULE OF SETTLEMENT SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON NONRECURRING BASIS SCHEDULE OF UNOBSERVABLE INPUT SCHEDULE OF DERIVATIVE INSTRUMENTS ON EARNINGS SCHEDULE OF FAIR VALUE MEASUREMENTS EMBEDDED DERIVATIVE LIABILITY SCHEDULE OF RECURRING BASIS FAIR VALUE MEASUREMENTS Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] SCHEDULE OF EXERCISE PRICE OF STOCK OPTIONS SCHEDULE OF STOCK OPTION ACTIVITY SCHEDULE OF OPTIONS GRANTED ASSUMPTIONS USING BLACK-SCHOLES OPTION SCHEDULE OF INFORMATION RELATED TO WARRANTS SUMMARY OF WARRANT ACTIVITY SCHEDULE OF RESTRICTED STOCK ACTIVITY SCHEDULE OF RESTRICTED STOCK UNITS GRANTS SCHEDULE OF ESTIMATED GRANT DATE FAIR VALUE SCHEDULE OF NON VESTED RESTRICTED ACTIVITY SCHEDULE OF RELATED TO WARRANTS SCHEDULE OF OUTSTANDING TO WARRANTS SCHEDULE OF NON-CONTROLLING INTEREST SCHEDULE OF CHANGES IN NON-CONTROLLING INTEREST SCHEDULE OF SEGMENT REPORTING OrganizationConsolidationAndPresentationOfFinancialStatementsTable [Table] Equity method investment, ownership percentage Other assets non current Variable interest entity acquired, percentage Variable interest entity acquired Working capital deficit Cash Net cash operating activities Net cash investing activities Net cash financing activities Secured debt Net proceeds Marketable securities Sale of trust assets Cash payments AccountingPoliciesTable [Table] Assets Consolidated asset percentage Intangible assets and goodwill Cash Prepaid expenses and other assets ComputationOfEarningPerShareTable [Table] Totals Cash Due from related party Sales tax receivable Prepaid expenses Trade name Developed technology Legal and compliance framework Goodwill Total assets acquired Accounts payable and accrued expenses Deferred tax liability Total liabilities assumed Net assets acquired Business Combination [Table] Business Combination [Line Items] Business acquisition, date Number of shares issued Exchangeable shares per purchased share Exchangeable shares issued, value Acquisition-related costs Business acquisition issuance of shares Business acquisition issuance of shares, value Number of shares issuance for acquisitions Finders fee, value Deferred tax liability Federal and provincial rate Finite lived intangible assets Royalty rate Discount rate Estimated useful lives Goodwill acquired Goodwill, beginning Acquisition Impairment Foreign currency translation adjustment Goodwill, ending Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Line Items] Total Foreign currency translation adjustment Total accumulated amortization Intangible assets, net Remainder 2026 2027 2028 2029 2030 Thereafter Intangible Asset, Indefinite-Lived [Table] Intangible Asset, Indefinite-Lived [Line Items] Amortization expenses Finite lived intangible asset, useful life Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] Total Less accumulated depreciation Property and equipment, net Depreciation Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Outstanding percentage Fair value of marketable securities Marketable securities cost Unrealized loss Dividend income Issuance of shares acquired Issuance of restricted shares Investments Issuance of shares Share price Fair value of investment Unrealized gain or loss Gross proceeds Realized gain Impairment charges DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTable [Table] Aggregate carrying value Other liabilities Inventory write-down Held for sale with carrying amount Cash proceeds Recognized gain sale of gold Purchase of gold assets Other assets held at cost - gold Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Assets Total assets Liabilities Accounts payable and accrued expenses Total liabilities Interest percentage Investement amount Variable interest percentage Net loss Variable interst entity Operating expense Minority interest Accrued accounting and legal Accrued consulting Accrued interest Accrued research and development expenses Accrued office and other Accrued insurance premium financing Accrued payroll Other accrued expenses Accounts payable and accrued expenses  Total Premium Paid as down payment Financed paid Finance charge Accounts Payable, Other Accounts payable, monthly installments Annual percentage rate Prepaid insurance Prepaid insurance premium financing Other separation-related obligations Loss on extinguishment of convertible debentures — prepayment premium Gain on derecognition of embedded derivative at settlement Realized loss on extinguishment of convertible debentures Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Face amount Stated interest rate Interest rate effective percentage Interest rate for basic Conversion price Share price Convertible debt Conversion of convertible shares Debt instrument fair value Interest expense Amortization of discounts and issuance costs Debt instrumental principal amount Debt principal amount Converitible debt Unamorization debt discount Cash payoff Debt instrument periodic payment Debt instrument accrued interest Principal conversion amount Number of shares issued Fair Value, off-Balance-Sheet Risk [Table] Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items] Fair value of intangible assets Goodwill Derivative liability measurement input Change in fair value of embedded derivative Balance as of December 31, 2025 Change in fair value Settlements Balance as of March 31, 2026 Embedded derivative liabilities – Yorkville Debentures Embedded derivative gain Embedded derivative liability Embedded derivative loss Gross proceeds Other income Stock, Class of Stock [Table] Class of Stock [Line Items] Temporary equity, liquidation preference Preferred stock, shares issued Preferred stock, shares outstanding Dividends payable Dividends payable Common stock conversion price Issued price Conversion of stock, shares converted Shares issued for services Conversion price Effective price Common stock shares, authorized Common stock share par value Common stock shares, issued Common stock shares, outstanding Exchangeable of common shares outstanding Sold to investors Adjustments to addtional paid issuance costs Gross proceed for stock offering Other offering expenses Proceeds from issuance of common stock Issuance cost Subscription amount Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Options Outstanding, Exercise Price Number of Options Outstanding Number of Options Outstanding Weighted Average Remaining Life Number of Options Outstanding Options Exercisable Options Outstanding, Exercise Price Outstanding shares Weighted Average Exercise Price Outstanding Weighted-Average Remaining Contractual Term Outstanding Aggregate Intrinsic Value Grants Weighted Average Exercise Price Grants Weighted-Average Remaining Contractual Term Forfeited/expired Weighted Average Exercise Price Forfeited/expired Outstanding shares Weighted Average Exercise Price Outstanding Outstanding Aggregate Intrinsic Value Outstanding shares Exercisable Weighted Average Exercise Price Outstanding Weighted-Average Remaining Contractual Term Outstanding Exercisable Aggregate Intrinsic Value Derivative liability Derivative liability, measurement input, expected life Exercise price Number outstanding Expiration date Restructuring Cost [Table] Restructuring Cost and Reserve [Line Items] Outstanding shares Weighted-Average Exercise Price ending Weighted-Average Remaining Contractual Term, Outstanding Issued Exercised Exercised Weighted-Average Exercise Price Exercised Outstanding shares Weighted-Average Exercise Price ending Warrants Vested and expected to vest, Shares Weighted-Average Exercise Price Vested and expected to vest Weighted-Average Remaining Contractual Term, Exercised Warrants Vested and expected to vest, Aggregate Intrinsic Value Warrants Exercisable, Shares Weighted-Average Exercise Price Exercisable Weighted-Average Remaining Contractual Term Exercisable Warrants Exercisable, Aggregate Intrinsic Value Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Total restricted shares outstanding Weighted average grant date fair value Granted Granted Vested Vested Forfeited Forfeited Total restricted shares outstanding Total Vested restricted shares Vested restricted shares, Weighted-Average Grant Date Fair Value Per Share Unvested restricted shares Unvested restricted, Weighted-Average Grant Date Fair Value Per Share Share-Based Compensation Arrangement by Share based payment award, non option equity instruments, granted Share based compensation arrangement by share-based payment award, award vesting rights Stock issued during the period, value ScheduleOfEstimatedGrantDateFairValueTable [Table] Stock price Stock price Expected volatility Interest rate Dividend yield Derived service period Share based compensation, price per share Nonvested as of December 31, 2025 Granted Vested and issued Forfeited Nonvested as of March 31, 2026 Restricted shares outstanding beginning balance Forfeited Restricted shares outstanding ending balance Vested restricted shares Unvested restricted shares Vested and unvested restricted shares total Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, beginning Weighted-Average Exercise Price, Outstanding Forfeited Expired Weighted-Average Exercise Price, Forfeited/expired Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Ending Weighted-Average Exercise Price, Outstanding Weighted-Average Remaining Contractual Term, Outstanding Exercisable warrants Weighted-Average Exercise Price, Exercisable Weighted-Average Remaining Contractual Term, Exercisable Warrants exercise price Warrants rights outstanding ScheduleOfOutstandingToWarrantsTable [Table] Shares authorized Exercise price Granted shares Weighted average exercise price Weighted average remaining contractual term Share based compensation Share based compensation expense Unrecognized compensation expense Shares of its common stock, warrants Warrants to purchase common stock Unrecognized stock-based compensation cost Weighted average period Other than options grants, GDFV Share based compensation, granted Other than options grants, milestone Weighted average grant date fair value Grant-date fair value Weighted average remaining contractual term Stock issued grant fair value Stock issued grant fair shares vesting Stock option description Stock issued during the period, conversion Stock issued during the period, conversion shares Stock issued during the period, other Share-based compensation, description Weighted average Years Employee share based compensation Shares available for future issuance ScheduleOfNonControllingInterestTable [Table] Majority interest Net loss Noncontrolling interest’s weighted-average ownership percentage Net loss attributable to non-controlling interest Balance, January 1, 2025 Net income (loss) attributable to non-controlling interest Balance, March 31, 2025 Consulting fees base fees Other prepaid expense Segment Reporting [Table] Segment Reporting [Line Items] Revenues General and administrative - stock-based compensation expenses Total operating and segment expense Realized gain on sale of gold Change in fair value of marketable securities Change in fair value of embedded derivative Realized loss on extinguishment of convertible debenture Gain on settlement and forgiveness of debt Income taxes (benefit) Number of reportable segment Related Party Transaction [Table] Related Party Transaction [Line Items] Other liabilities Subsequent Event [Table] Subsequent Event [Line Items] Dividend payment description Number of shares granted Shares issued Shares vested Shares converted Sales tax receivable. Series C 9% Convertible Preferred Stock [Member] GainLossOnSettlementAndForgivenessOfAccountsPayable Change in fair value of embedded derivative. Change in fair value of marketable securities. Stock issued during period value underwritten public offering. Stock issued during period shares underwritten public offering. Stock issued during period value conversion of convertible debentures into common stock. Stock issued during period shares conversion of convertible debenture into common stock. Issuance of equity to non controlling interest holders. Other comprehensive income. Increase decrease in sales tax receivable. Gain on settlement and extinguishment of accounts payable. Proceeds from sale of gold. Proceeds from sale of common stock under at the market offerings net of issuance costs. Repayment of finance obligation. Repayment of convertible debentures. Dividend payable on preferred stock charged to additional paid in capital. Conversion of convertible debentures into common stock. Working captal deficit Gold Assets [Policy Text Block] Common stock issued in settlement of accounts payable. Viral Clear [Member] BioSig AI Sciences, Inc. [Member] Streamex Ltd [Member] Concentration Of Assets [Policy Text Block] Consolidated asset percentage. Recently Adopted Accounting Pronouncements Policy [Policy Text Block] Streamex Exchange Corporation [Member] Share Purchase Agreement [Member] Business combination recognized identifiable assets acquired and liabilities assumed due from related party Business combination recognized identifiable assets acquired and liabilities assumed sales tax receivable. Business combination recognized identifiable assets acquired and liabilities assumed trade name. Business combination recognized identifiable assets acquired and liabilities assumed developed technology. Business combination recognized identifiable assets acquired and liabilities assumed legal and compliance framework. Business combination recognized identifiable assets acquired and liabilities assumed goodwill. Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accounts payable and accrued expenses. Federal and provincial rate. Royalty rate. Discount rate. Securitization Platform [Member] Blockchain Integration [Member] Legal and Compliance Frame Work [Member] Foreign currency translation adjustment Compliance Framework [Member] Outstanding percentage. Unrealized loss. Empress Royalty Corp [Member] Restricted [Member] Unrestricted [Member] Brinks Bailee Agreement [Member] Fair value of derivative liability. Settlements. Restricted Gold [Member] Variable interest percentage. Cumulative dividends payable, Preferred stock convertible effective price. Chief Invest Officer [Member] General Counsel Officers [Member] Operating expense. Accrued consulting current. Accrued interest current. Accrued research and development expenses. Accrued office expense and other expense. Accrued insurance premium financing. Premium Finance Agreement [Member] Sales Agreement [Member] Accounts payable monthly installments. Annual percentage rate. Other separation related obligations. 2023 Long-Term Incentive Plan [Member] Options Under 9.99 [Member] Options 10.00 To 19.99 [Member] Options 20.00 To 49.99 [Member] Options 50.00 To 69.99 [Member] Finite lived intangible assets amortization expense after year four. Sharebased compensation arrangement by sharebased payment award options issued weighted average remaining contractual term 2. Weighted average remaining contractual term options outstanding. GLDY ServiceCo, LLC [Member] Share based compensation arrangement by share based payment award options exercisable weighted average remaining contractual term. Realized gain on marketable securities. Proceeds from issuance of sale of equity. Schedule of Warrants or Rights Shares Authorized Exercise Price Range [Table Text Block] Warrants At 0.3000 [Member] Warrants At 0.9547 [Member] Warrants At 17800 [Member] Warrants At 40660 [Member] Warrants At 44550 [Member] Warrants At 46626 [Member] Marketable securities realized gain. Warrants At 44660 [Member] Warrants At 49252 [Member] Warrants At 49290 [Member] Warrants At 51358 [Member] Warrants At 71810 [Member] Warrants At 75020 [Member] Warrants At 79630 [Member] Warrants At 90000 [Member] Warrants At 95960 [Member] Warrants At 100992 [Member] Warrants At 102600 [Member] Warrants At 104678 [Member] Warrants At 113000 [Member] Warrants At 132800 [Member] Warrants At 480000 [Member] Warrants At 616000 [Member] Warrants At 33640 [Member] Warrants expiration date description. Class of warrants or right issued. Class of warrantsr or right expried. Class of warrants or right exercised. Class of warrant or rights vested and expected to vest outstanding. Class of warrant or rights exercisable. Class of warrant or rights weighted average exercise price of warrants or rights outstanding. Class of warrant or right exercise price of warrants or rights exercised. Class of warrant or rights weighted average exercise price of warrants or rights vested and expected to vest outstanding. Class of warrant or rights weighted average exercise price of warrants or rights exercisable. Warrants outstanding weighted average remaining contractual term. Warrants weighted average remaining contractual term exercised. Warrants exercisable weighted average remaining contractual term. Shares issued for cashless exercise of warrants. Viral Clear Pharmaceuticals Inc [Member] Share based compensation arrangement by share based payment award equity instruments other than options vested number of shares. Share based compensation arrangement by share based payment award equity instruments other than options unvested number of shares. Schedule of NonControlling Interest [Table Text Block] Bio Sig AI Sciences Inc [Member] Net Income (Loss) Average noncontrolling interest percentage of profit losses. Consulting fees. Base fees. General and administrative stock based compensation expenses. Embedded derivative gain on embedded derivatives. One One Two Thousand Twenty Six [Member] Third Party Consultant [Member] One Eight Two Thousand Twenty Six [Member] Interim Executive Chairman [Member] Chief Executive Officier [Member] One Twenty Seven Two Thousand Twenty Six [Member] Two One Two Thousand Twenty Six [Member] Three Three Two Thousand Twenty Six [Member] Three Sixteen Two Thousand Twenty Six [Member] Common Stock One [Member] Common Stock Two [Member] Common Stock Three [Member] Common Stock Four [Member] Common Stock Five [Member] Granted share price. Performance shares And AUM [Member] Share based compensation arrangement by share based payment award options grants in period issued. Class of warrants or rights exercisable. Class of warrant or rights weighted average exercise price of warrant or rights exercisable. Warrants vested and expected to vest outstanding weighted average remaining contractual terms. Warrants exercisable weighted average remaining contractual terms. Share based compensation arrangement by share based payment award options grant in period gross. Schedule of warrants. Class of warrants or right outstanding. Share based compensation arrangement by share based payment award option non vested number of shares. Share based compensation arrangement by share based payment award option outstanding weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instrument outstanding number. Share based compensation arrangement by share based payment award equity instruments other than option unvested number of shares. Share based compensation arrangement by share based payment award equity instruments other than option unvested total number of shares. Schedule of outstanding warrants. Share Based Compensation Award Tranche Four [Member] Share Based Compensation Award Tranche Five [Member] Restricted Stock One [Member] Restricted Stock Two [Member] Stock option description. Share Based Compensation Award Tranche [Member] Chief Investment Officer [Member] Employment Agreement [Member] Performance Vesting Restricted Stock Units [Member] Third Party [Member] Six Month Anniversaries [Member] Twelve Month Anniversaries [Member] Common stock issued to settle accounts payable, shares. Common stock issued to settle accounts payable. Two Related Party [Member] Schedule of Effect of Significant Unobservable Inputs [Table Text Block] Measurement Input Common Stock Price [Member] Measurement Input Indicated Conversion Price [Member] Measurement Input Floor Price [Member] Measurement Input Prepayment Premium [Member] Measurement Input Registration Probability [Member] Third party Consultants [Member] Business combination acquisition finders fee. Share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date. Share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date. Range One [Member] Performance Based Restricted Stock Unit [Member] Testing and Demo Equipment [Member] Developed Technology [Member] Assets, Current Assets, Noncurrent Liabilities, Current Equity, Attributable to Parent Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Dividends, Preferred Stock Preferred Stock Dividends, Income Statement Impact Net Income (Loss) Available to Common Stockholders, Basic Weighted Average Number of Shares Outstanding, Diluted Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings GainOnSettlementAndExtinguishmentOfAccountsPayable Increase (Decrease) in Accounts Receivable Increase (Decrease) in Leasing Receivables IncreaseDecreaseInSalesTaxReceivable Increase (Decrease) in Prepaid Expense Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Payments to Acquire Marketable Securities Payments to Acquire Mining Assets Cash Provided by (Used in) Investing Activity, Including Discontinued Operation RepaymentOfFinanceObligation RepaymentOfConvertibleDebentures Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation ConversionOfConvertibleDebenturesIntoCommonStock Cash and Cash Equivalent Cash Equivalents, at Carrying Value Long-Term Investments Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDueFromRelatedParty BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSalesTaxReceivable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill Business Combination, Recognized Asset Acquired, Asset BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedExpenses Business Combination, Recognized Liability Assumed, Deferred Tax Liability Business Combination, Recognized Liability Assumed, Liability Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) Deferred Tax Liabilities, Goodwill and Intangible Assets Foreign currency translation adjustment [Default Label] Intangible Asset, Finite-Lived, Accumulated Amortization Intangible Asset, Finite-Lived, after Accumulated Amortization Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization Extinguishment of Debt, Amount Debt Securities, Realized Gain (Loss) Goodwill, Fair Value Disclosure Dividends Payable CumulativeDividendsPayable Preferred Stock, Convertible, Conversion Price Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm2 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Class of warrant or rights weighted average exercise price of warrants or rights outstanding Class of warrants or right exercised Class of warrant or rights vested and expected to vest outstanding ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsVestedAndExpectedToVestOutstanding Class of warrant or rights exercisable ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberOfShares ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnvestedNumberOfShares ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDate Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionNonvestedNumberOfShares Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price WarrantsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms ClassOfWarrantsOrRightsExercisable ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantOrRightsExercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted-Average Remaining Contractual Term Net Income (Loss) Debt Securities, Available-for-Sale, Realized Loss Equity Securities, FV-NI, Gain (Loss) Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Other Liabilities, Current